Literature DB >> 23891556

Antigen 85 variation across lineages of Mycobacterium tuberculosis-implications for vaccine and biomarker success.

Nicole A Kruh-Garcia1, Madeleine Murray1, John G Prucha1, Karen M Dobos2.   

Abstract

Mycobacterium tuberculosis secretes several hundred proteins; many of which elicit immune responses. As a result, many of these proteins have been explored for their potential as diagnostic and vaccine candidates. Of these, the Antigen 85 complex proteins, represented by Antigen85 A, B, and C, are the most studied from the mycobacterial secretome. However, vaccine constructs exploiting Antigen 85 as the sole antigen repertoire have not experienced the pre-clinical and clinical trials success originally anticipated. Anecdotal and biochemical evidence suggests that differences in protein abundance may explain this phenomenon. Here, biochemical, molecular, and mass spectrometry approaches were used to quantify Antigen 85 among six M. tuberculosis strains from four phylogenetically distinct clades. Our data demonstrates that the greatest variation in Antigen 85 is ascribed to protein quantities, whereas few transcriptional differences were found. In addition, the ratio of Antigen 85 A, to B, to C is conserved within clades and phylogenetic neighbors. In contrast, no such relationship between individual protein quantities was observed, and in the case of Antigen85 B, this variation even extends within biological replicates of individual isolates. The relevance of Antigen 85 protein quantities and vaccine efficacy remains to be defined. BIOLOGICAL SIGNIFICANCE: Absolute quantitation via multiple reaction monitoring mass spectrometry was used to determine the exact molar concentrations of Antigen 85A, B, and C; three key immunodominant proteins present in M. tuberculosis. Further, the concentration of these three proteins was compared among various clades of M. tuberculosis, and demonstrated differences in abundance of two of the three proteins. These proteins have been identified as key antigens in multiple vaccine and diagnostic platforms, thus the potential relevance of their abundance in various M. tuberculosis clades to the successful outcome of these interventions is discussed. This article is part of a Special Issue entitled: Trends in Microbial Proteomics.
© 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antigen; MRM; Tuberculosis; Vaccine

Mesh:

Substances:

Year:  2013        PMID: 23891556     DOI: 10.1016/j.jprot.2013.07.005

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  9 in total

Review 1.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

2.  Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System.

Authors:  Annuurun Nisa; Claudio Counoupas; Rachel Pinto; Warwick J Britton; James A Triccas
Journal:  Vaccines (Basel)       Date:  2022-06-14

3.  Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC.

Authors:  Luisa Maria Nieto R; Carolina Mehaffy; Elizabeth Creissen; JoLynn Troudt; Amber Troy; Helle Bielefeldt-Ohmann; Marcos Burgos; Angelo Izzo; Karen M Dobos
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

4.  Potential of High-Affinity, Slow Off-Rate Modified Aptamer Reagents for Mycobacterium tuberculosis Proteins as Tools for Infection Models and Diagnostic Applications.

Authors:  Theresa M Russell; Louis S Green; Taylor Rice; Nicole A Kruh-Garcia; Karen Dobos; Mary A De Groote; Thomas Hraha; David G Sterling; Nebojsa Janjic; Urs A Ochsner
Journal:  J Clin Microbiol       Date:  2017-08-09       Impact factor: 5.948

5.  Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum.

Authors:  Carolina Mehaffy; Karen M Dobos; Payam Nahid; Nicole A Kruh-Garcia
Journal:  Clin Proteomics       Date:  2017-06-05       Impact factor: 3.988

6.  Inferring biomarkers for Mycobacterium avium subsp. paratuberculosis infection and disease progression in cattle using experimental data.

Authors:  Gesham Magombedze; Tinevimbo Shiri; Shigetoshi Eda; Judy R Stabel
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

7.  Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis.

Authors:  Santosh Kumar; Ashima Bhaskar; Gautam Patnaik; Chetan Sharma; Dhiraj Kumar Singh; Sandeep Rai Kaushik; Shivam Chaturvedi; Gobardhan Das; Ved Prakash Dwivedi
Journal:  JCI Insight       Date:  2021-02-22

Review 8.  Review of Liquid Chromatography-Mass Spectrometry-Based Proteomic Analyses of Body Fluids to Diagnose Infectious Diseases.

Authors:  Hayoung Lee; Seung Il Kim
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

9.  Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS.

Authors:  Nicole A Kruh-Garcia; Lisa M Wolfe; Lelia H Chaisson; William O Worodria; Payam Nahid; Jeff S Schorey; J Lucian Davis; Karen M Dobos
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.